-
New AI tool may help personalize multiple myeloma treatment
An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.On : 19-Jun-2026- Source : Medical Xpress -
Personalized mRNA vaccine targets osteosarcoma relapse in first human use
In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer vaccine designed to prevent recurrence of osteosarcoma, a rare and aggressive type of bone cancer.On : 19-Jun-2026- Source : Medical Xpress -
Novel combination therapy could reduce leukemia relapse rate extending window for bone marrow transplants
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment outcomes and survival in patients with acute myeloid leukemia (AML) with FLT3 g...On : 19-Jun-2026- Source : Medical Xpress -
PSMA PET reveals bone metastases missed by standard imaging
Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases in prostate cancer patients, a critical indicator of a patient`s long-term survival.On : 19-Jun-2026- Source : Medical Xpress -
Oral therapy enables athome treatment for acute myeloid leukemia
For years, treatment of older patients with acute myeloid leukemia-an aggressive cancer of the blood and bone marrow-has required injections administered in a clinic for five to seven consecutive days each month, in addition to an oral pill.On : 19-Jun-2026- Source : Medical Xpress -
Abemaciclib may be new standard for challenging sarcoma subtype
Abemaciclib significantly prolonged PFS compared with placebo for patients with advanced dedifferentiated liposarcoma, according to findings presented during ASCO Annual Meeting’s plenary session.On : 19-Jun-2026- Source : Healio -
The Pericapsular Nerve Group Block in Hip Arthroscopy Not a Miracle But Ignoring it is no Longer an Option
Hip arthroscopy has largely transitioned to an outpatient procedure.1 Yet, postoperative pain management in many centers continues to reflect an inpatient mindset. We still accept “reasonable” pain levels and “modest” opioid requirements, even though both directly affect discharge efficiency...On : 19-Jun-2026- Source : The Journal of Arthroscopic and Related Surgery -
Endoscopic Hamstring Repair The Evolving Standard from Open Management for Experienced Hip Arthroscopists
Endoscopic proximal hamstring repair represents an evolution in the surgical management of posterior hip pathology. Mastery of this technique requires progression beyond intra-articular and peritrochanteric hip arthroscopy into the technically demanding subgluteal space. In experienced hands, the en...On : 19-Jun-2026- Source : The Journal of Arthroscopic and Related Surgery -
Older or TobaccoUsing Patients Warrant Discussion of Proximal Femur Fracture after Hip Arthroscopy
Hip arthroscopy offers promising outcomes for femoroacetabular impingement syndrome and labral pathology, yet patient selection remains one of the strongest determinants for successful outcomes. Although complication rates are low, especially in regard to proximal femur fractures, data has shown tha...On : 19-Jun-2026- Source : The Journal of Arthroscopic and Related Surgery -
Total Hip Arthroplasty after Hip Preservation Surgery Outcomes and Challenges
Hip preservation surgery (HPS) is increasingly performed in young and active patients with the aim of delaying or avoiding total hip arthroplasty (THA). Despite advances in preservation techniques, a proportion of patients eventually progress to end-stage hip disease and require conversion to THA.On : 19-Jun-2026- Source : ScienceDirect

